├── _config.yml ├── .gitignore ├── templates ├── Text.html ├── Composition.html ├── Immunizations.html ├── Problems.html ├── Allergies.html ├── Patient.html └── Medications.html ├── README.md ├── demo.html ├── LICENSE ├── ips-argentina-ejemplo.json └── ips-example-bundle.json /_config.yml: -------------------------------------------------------------------------------- 1 | theme: jekyll-theme-minimal -------------------------------------------------------------------------------- /.gitignore: -------------------------------------------------------------------------------- 1 | # Compiled class file 2 | *.class 3 | 4 | # Log file 5 | *.log 6 | 7 | # BlueJ files 8 | *.ctxt 9 | 10 | # Mobile Tools for Java (J2ME) 11 | .mtj.tmp/ 12 | 13 | # Package Files # 14 | *.jar 15 | *.war 16 | *.nar 17 | *.ear 18 | *.zip 19 | *.tar.gz 20 | *.rar 21 | 22 | # virtual machine crash logs, see http://www.java.com/en/download/help/error_hotspot.xml 23 | hs_err_pid* 24 | -------------------------------------------------------------------------------- /templates/Text.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | {{titulo}} 7 |
8 |
9 | {{div}} 10 |
11 |
-------------------------------------------------------------------------------- /templates/Composition.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | Encabezado 7 |
8 |
9 |
{{title}}
10 |

11 | Fecha del Resumen: {{date}} 12 |
13 | Dominio: {{custodian.name}}, {{custodian.address[0].city}}, {{custodian.address[0].country}} 14 |

15 |
16 |
-------------------------------------------------------------------------------- /templates/Immunizations.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | Vacunas 7 |
8 |
9 | 17 |
18 |
-------------------------------------------------------------------------------- /templates/Problems.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | Diagnósticos / Problemas activos 7 |
8 |
9 | 17 |
18 |
-------------------------------------------------------------------------------- /templates/Allergies.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | Alergias e Intolerancias 7 |
8 |
9 | 26 |
27 |
-------------------------------------------------------------------------------- /templates/Patient.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | Datos del Paciente 7 |
8 |
9 |
10 |     11 | {{each(options.name)}} 12 | {{@this.family}},  13 | {{each(options.name[@index].given)}} 14 | {{@this}} 15 | {{/each}} 16 | {{/each}} 17 |
18 |

19 | Fecha de Nacimiento: {{birthDate}} 20 |
21 | Contacto:  22 | {{each(options.telecom)}} 23 |  {{@this.value}} 24 | {{/each}} 25 |
26 | Identificadores:
27 | 28 | {{each(options.identifier)}} 29 |       {{@this.system}}: {{@this.value}}
30 | {{/each}} 31 |
32 |

33 |
34 |
-------------------------------------------------------------------------------- /README.md: -------------------------------------------------------------------------------- 1 | # Resumen Electrónico de Historia Clínica 2 | 3 | En el contexto de la [Estrategia Nacional de Salud Digital](https://www.argentina.gob.ar/noticias/se-aprobo-la-estrategia-nacional-de-salud-digital-2018-2024) que lleva cabo el Ministerio de Salud de la Nación en Argentina, se implementa la Red Nacional de Interoperabilidad que va a permitir la comunicación de información sanitaria entre instituciones de salud, en forma segura y privada. 4 | 5 | El grupo de trabajo para la implementación del resumen de historia clínica electrónica esta diseñando y piloteando la transferencia de información basada en el estándar internacional [IPS (Internacional Patient Summary)](http://wiki.hl7.org/index.php?title=International_Patient_Summary_(IPS)) y [HL7 FHIR](https://www.hl7.org/fhir/). 6 | 7 | Este repositorio es un area de trabajo de este grupo y contiene versiones de prueba del estándar propuesto. 8 | 9 | ## Demo 10 | 11 | Este es un visor de resúmenes de paciente IPS compatibles. 12 | 13 | https://salud-ar.github.io/IPS-Argentina/demo.html 14 | 15 | ## Piloto 16 | 17 | Durante la etapa piloto de la implementación del resumen de Historia Clínica Electrónica se han priorizado la siguiente lista de componentes: 18 | 19 | 1. Alergias 20 | 2. Lista de problemas o diagnósticos activos 21 | 3. Inmunizaciones 22 | 4. Medicación 23 | 24 | Todos los elementos clínicos, alergias, diagnósticos, vacunas y medicamentos se codifican con códigos de la [edición argentina de SNOMED CT](https://www.argentina.gob.ar/salud/snomed). 25 | 26 | ## Más información 27 | 28 | Las definiciones formales de los estándares de interoperabilidad se publicarán en el sitio de documentación del proyecto de salud digital: 29 | 30 | https://simplifier.net/SaludDigital.ar 31 | 32 | -------------------------------------------------------------------------------- /templates/Medications.html: -------------------------------------------------------------------------------- 1 |
2 |
3 | 4 | 5 | 6 | Medicamentos activos 7 |
8 |
9 | 67 |
68 |
-------------------------------------------------------------------------------- /demo.html: -------------------------------------------------------------------------------- 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 11 | 12 | 13 | 14 | 15 | 18 | 21 | 22 | 40 | 41 | Resumen Electrónico de Historia Clínica 42 | 43 | 44 | 170 |

Resumen Electrónico de Historia Clínica

171 |
172 |
173 |
174 |
175 | 176 |
177 | 178 |
179 | 180 | 181 | 182 | 185 | 193 | 194 | 195 |          196 | 197 | 198 |
199 |
200 |
201 |
202 |
203 |
204 |
205 |
206 |
207 |
208 |
209 |
210 |
211 |
212 |
213 |
214 |
215 |
216 |
217 |
218 |
219 |
220 |
221 |
222 |
223 | 224 | 225 | -------------------------------------------------------------------------------- /LICENSE: -------------------------------------------------------------------------------- 1 | Apache License 2 | Version 2.0, January 2004 3 | http://www.apache.org/licenses/ 4 | 5 | TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION 6 | 7 | 1. Definitions. 8 | 9 | "License" shall mean the terms and conditions for use, reproduction, 10 | and distribution as defined by Sections 1 through 9 of this document. 11 | 12 | "Licensor" shall mean the copyright owner or entity authorized by 13 | the copyright owner that is granting the License. 14 | 15 | "Legal Entity" shall mean the union of the acting entity and all 16 | other entities that control, are controlled by, or are under common 17 | control with that entity. For the purposes of this definition, 18 | "control" means (i) the power, direct or indirect, to cause the 19 | direction or management of such entity, whether by contract or 20 | otherwise, or (ii) ownership of fifty percent (50%) or more of the 21 | outstanding shares, or (iii) beneficial ownership of such entity. 22 | 23 | "You" (or "Your") shall mean an individual or Legal Entity 24 | exercising permissions granted by this License. 25 | 26 | "Source" form shall mean the preferred form for making modifications, 27 | including but not limited to software source code, documentation 28 | source, and configuration files. 29 | 30 | "Object" form shall mean any form resulting from mechanical 31 | transformation or translation of a Source form, including but 32 | not limited to compiled object code, generated documentation, 33 | and conversions to other media types. 34 | 35 | "Work" shall mean the work of authorship, whether in Source or 36 | Object form, made available under the License, as indicated by a 37 | copyright notice that is included in or attached to the work 38 | (an example is provided in the Appendix below). 39 | 40 | "Derivative Works" shall mean any work, whether in Source or Object 41 | form, that is based on (or derived from) the Work and for which the 42 | editorial revisions, annotations, elaborations, or other modifications 43 | represent, as a whole, an original work of authorship. For the purposes 44 | of this License, Derivative Works shall not include works that remain 45 | separable from, or merely link (or bind by name) to the interfaces of, 46 | the Work and Derivative Works thereof. 47 | 48 | "Contribution" shall mean any work of authorship, including 49 | the original version of the Work and any modifications or additions 50 | to that Work or Derivative Works thereof, that is intentionally 51 | submitted to Licensor for inclusion in the Work by the copyright owner 52 | or by an individual or Legal Entity authorized to submit on behalf of 53 | the copyright owner. For the purposes of this definition, "submitted" 54 | means any form of electronic, verbal, or written communication sent 55 | to the Licensor or its representatives, including but not limited to 56 | communication on electronic mailing lists, source code control systems, 57 | and issue tracking systems that are managed by, or on behalf of, the 58 | Licensor for the purpose of discussing and improving the Work, but 59 | excluding communication that is conspicuously marked or otherwise 60 | designated in writing by the copyright owner as "Not a Contribution." 61 | 62 | "Contributor" shall mean Licensor and any individual or Legal Entity 63 | on behalf of whom a Contribution has been received by Licensor and 64 | subsequently incorporated within the Work. 65 | 66 | 2. Grant of Copyright License. Subject to the terms and conditions of 67 | this License, each Contributor hereby grants to You a perpetual, 68 | worldwide, non-exclusive, no-charge, royalty-free, irrevocable 69 | copyright license to reproduce, prepare Derivative Works of, 70 | publicly display, publicly perform, sublicense, and distribute the 71 | Work and such Derivative Works in Source or Object form. 72 | 73 | 3. Grant of Patent License. Subject to the terms and conditions of 74 | this License, each Contributor hereby grants to You a perpetual, 75 | worldwide, non-exclusive, no-charge, royalty-free, irrevocable 76 | (except as stated in this section) patent license to make, have made, 77 | use, offer to sell, sell, import, and otherwise transfer the Work, 78 | where such license applies only to those patent claims licensable 79 | by such Contributor that are necessarily infringed by their 80 | Contribution(s) alone or by combination of their Contribution(s) 81 | with the Work to which such Contribution(s) was submitted. If You 82 | institute patent litigation against any entity (including a 83 | cross-claim or counterclaim in a lawsuit) alleging that the Work 84 | or a Contribution incorporated within the Work constitutes direct 85 | or contributory patent infringement, then any patent licenses 86 | granted to You under this License for that Work shall terminate 87 | as of the date such litigation is filed. 88 | 89 | 4. Redistribution. You may reproduce and distribute copies of the 90 | Work or Derivative Works thereof in any medium, with or without 91 | modifications, and in Source or Object form, provided that You 92 | meet the following conditions: 93 | 94 | (a) You must give any other recipients of the Work or 95 | Derivative Works a copy of this License; and 96 | 97 | (b) You must cause any modified files to carry prominent notices 98 | stating that You changed the files; and 99 | 100 | (c) You must retain, in the Source form of any Derivative Works 101 | that You distribute, all copyright, patent, trademark, and 102 | attribution notices from the Source form of the Work, 103 | excluding those notices that do not pertain to any part of 104 | the Derivative Works; and 105 | 106 | (d) If the Work includes a "NOTICE" text file as part of its 107 | distribution, then any Derivative Works that You distribute must 108 | include a readable copy of the attribution notices contained 109 | within such NOTICE file, excluding those notices that do not 110 | pertain to any part of the Derivative Works, in at least one 111 | of the following places: within a NOTICE text file distributed 112 | as part of the Derivative Works; within the Source form or 113 | documentation, if provided along with the Derivative Works; or, 114 | within a display generated by the Derivative Works, if and 115 | wherever such third-party notices normally appear. The contents 116 | of the NOTICE file are for informational purposes only and 117 | do not modify the License. You may add Your own attribution 118 | notices within Derivative Works that You distribute, alongside 119 | or as an addendum to the NOTICE text from the Work, provided 120 | that such additional attribution notices cannot be construed 121 | as modifying the License. 122 | 123 | You may add Your own copyright statement to Your modifications and 124 | may provide additional or different license terms and conditions 125 | for use, reproduction, or distribution of Your modifications, or 126 | for any such Derivative Works as a whole, provided Your use, 127 | reproduction, and distribution of the Work otherwise complies with 128 | the conditions stated in this License. 129 | 130 | 5. Submission of Contributions. Unless You explicitly state otherwise, 131 | any Contribution intentionally submitted for inclusion in the Work 132 | by You to the Licensor shall be under the terms and conditions of 133 | this License, without any additional terms or conditions. 134 | Notwithstanding the above, nothing herein shall supersede or modify 135 | the terms of any separate license agreement you may have executed 136 | with Licensor regarding such Contributions. 137 | 138 | 6. Trademarks. This License does not grant permission to use the trade 139 | names, trademarks, service marks, or product names of the Licensor, 140 | except as required for reasonable and customary use in describing the 141 | origin of the Work and reproducing the content of the NOTICE file. 142 | 143 | 7. Disclaimer of Warranty. Unless required by applicable law or 144 | agreed to in writing, Licensor provides the Work (and each 145 | Contributor provides its Contributions) on an "AS IS" BASIS, 146 | WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or 147 | implied, including, without limitation, any warranties or conditions 148 | of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A 149 | PARTICULAR PURPOSE. You are solely responsible for determining the 150 | appropriateness of using or redistributing the Work and assume any 151 | risks associated with Your exercise of permissions under this License. 152 | 153 | 8. Limitation of Liability. In no event and under no legal theory, 154 | whether in tort (including negligence), contract, or otherwise, 155 | unless required by applicable law (such as deliberate and grossly 156 | negligent acts) or agreed to in writing, shall any Contributor be 157 | liable to You for damages, including any direct, indirect, special, 158 | incidental, or consequential damages of any character arising as a 159 | result of this License or out of the use or inability to use the 160 | Work (including but not limited to damages for loss of goodwill, 161 | work stoppage, computer failure or malfunction, or any and all 162 | other commercial damages or losses), even if such Contributor 163 | has been advised of the possibility of such damages. 164 | 165 | 9. Accepting Warranty or Additional Liability. While redistributing 166 | the Work or Derivative Works thereof, You may choose to offer, 167 | and charge a fee for, acceptance of support, warranty, indemnity, 168 | or other liability obligations and/or rights consistent with this 169 | License. However, in accepting such obligations, You may act only 170 | on Your own behalf and on Your sole responsibility, not on behalf 171 | of any other Contributor, and only if You agree to indemnify, 172 | defend, and hold each Contributor harmless for any liability 173 | incurred by, or claims asserted against, such Contributor by reason 174 | of your accepting any such warranty or additional liability. 175 | 176 | END OF TERMS AND CONDITIONS 177 | 178 | APPENDIX: How to apply the Apache License to your work. 179 | 180 | To apply the Apache License to your work, attach the following 181 | boilerplate notice, with the fields enclosed by brackets "[]" 182 | replaced with your own identifying information. (Don't include 183 | the brackets!) The text should be enclosed in the appropriate 184 | comment syntax for the file format. We also recommend that a 185 | file or class name and description of purpose be included on the 186 | same "printed page" as the copyright notice for easier 187 | identification within third-party archives. 188 | 189 | Copyright [yyyy] [name of copyright owner] 190 | 191 | Licensed under the Apache License, Version 2.0 (the "License"); 192 | you may not use this file except in compliance with the License. 193 | You may obtain a copy of the License at 194 | 195 | http://www.apache.org/licenses/LICENSE-2.0 196 | 197 | Unless required by applicable law or agreed to in writing, software 198 | distributed under the License is distributed on an "AS IS" BASIS, 199 | WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. 200 | See the License for the specific language governing permissions and 201 | limitations under the License. 202 | -------------------------------------------------------------------------------- /ips-argentina-ejemplo.json: -------------------------------------------------------------------------------- 1 | { 2 | "resourceType" : "Bundle", 3 | "id" : "Resumen-HC-IPS-SaludDigital.ar", 4 | "meta" : { 5 | "lastUpdated" : "2018-01-26T14:30:00-03:00" 6 | }, 7 | "language" : "es-AR", 8 | "entry" : [ 9 | { 10 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/Composition\/IPS-examples-Composition-01", 11 | "resource" : { 12 | "id" : "IPS-Composition-01", 13 | "subject" : { 14 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Patient\/IPS-examples-Patient-01" 15 | }, 16 | "section" : [ 17 | { 18 | "code" : { 19 | "coding" : [ 20 | { 21 | "system" : "http:\/\/loinc.org", 22 | "display" : "Problem list", 23 | "code" : "11450-4" 24 | } 25 | ] 26 | }, 27 | "entry" : [ 28 | { 29 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Condition\/IPS-examples-Condition-01" 30 | } 31 | ], 32 | "title" : "Problemas", 33 | "text" : { 34 | "status" : "generated", 35 | "div" : "
asma (trastorno)<\/div>" 36 | } 37 | }, 38 | { 39 | "code" : { 40 | "coding" : [ 41 | { 42 | "system" : "http:\/\/loinc.org", 43 | "display" : "Medication use", 44 | "code" : "10160-0" 45 | } 46 | ] 47 | }, 48 | "entry" : [ 49 | { 50 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/MedicationStatement\/IPS-examples-MedicationStatement-01" 51 | } 52 | ], 53 | "title" : "Medicamentos", 54 | "text" : { 55 | "status" : "additional", 56 | "div" : "
\n \n \n \n \n \n
Medicamento<\/th>\n Strength<\/th>\n Forma<\/th>\n Dosis<\/th>\n Comentario<\/th>\n <\/tr>\n <\/thead>\n
salbutamol (sustancia)<\/td>\n 200 mcg<\/td>\n disparo<\/td>\n uno por día<\/td>\n tratamiento de asma<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n <\/div>" 57 | } 58 | }, 59 | { 60 | "code" : { 61 | "coding" : [ 62 | { 63 | "system" : "http:\/\/loinc.org", 64 | "display" : "Allergies and\/or adverse reactions", 65 | "code" : "48765-2" 66 | } 67 | ] 68 | }, 69 | "entry" : [ 70 | { 71 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/AllergyIntolerance\/IPS-examples-AllergyIntolerance-01" 72 | } 73 | ], 74 | "title" : "Alergias", 75 | "text" : { 76 | "status" : "generated", 77 | "div" : "
Alergia a penicilina (trastorno), criticidad alta, activo<\/div>" 78 | } 79 | }, 80 | { 81 | "title" : "Vacunas", 82 | "text" : { 83 | "status" : "generated", 84 | "div" : "
producto que contiene solamente antígeno de virus de la influenza (producto medicinal)<\/div>" 85 | }, 86 | "code" : { 87 | "coding" : [ 88 | { 89 | "system" : "http:\/\/loinc.org", 90 | "display" : "Immunization record", 91 | "code" : "60484-3" 92 | } 93 | ] 94 | }, 95 | "entry" : [ 96 | { 97 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Immunization\/IPS-examples-Immunization-01" 98 | } 99 | ] 100 | } 101 | ], 102 | "resourceType" : "Composition", 103 | "author" : [ 104 | { 105 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Device\/IPS-examples-Device-01" 106 | } 107 | ], 108 | "confidentiality" : "N", 109 | "type" : { 110 | "coding" : [ 111 | { 112 | "system" : "http:\/\/loinc.org", 113 | "display" : "Patient Summary", 114 | "code" : "60591-5" 115 | } 116 | ] 117 | }, 118 | "title" : "Resumen del paciente al 26 de Enero de 2018, 14:30hs", 119 | "identifier" : { 120 | "system" : "http://hospitalPintos.org.ar/Composition", 121 | "value" : "10501" 122 | }, 123 | "date" : "2018-01-26T14:30:00-03:00", 124 | "meta" : { 125 | "profile" : [ 126 | "http:\/\/hl7.org\/fhir\/uv\/ips\/StructureDefinition\/composition-uv-ips" 127 | ] 128 | }, 129 | "text" : { 130 | "status" : "generated", 131 | "div" : "

Generated Narrative with Details<\/b><\/p>

id<\/b>: IPS-examples-Composition-01<\/p>

meta<\/b>: <\/p>

text<\/b>: <\/p>

identifier<\/b>: 10501<\/p>

status<\/b>: FINAL<\/p>

type<\/b>: Patient Summary (Details : {LOINC code '60591-5' = 'Patient summary Document', given as 'Patient Summary'})<\/span><\/p>

date<\/b>: 26\/01\/2018 14:30:00 PM<\/p>

author<\/b>: Generated Summary: id: IPS-examples-Device-01; Sistema HCE del Hospital Municipal Dr Angel Pintos <\/a><\/p>

title<\/b>: Patient Summary as of January 26, 2018 14:30<\/p>

confidentiality<\/b>: N<\/p>

attester<\/b><\/p>

mode<\/b>: LEGAL<\/p>

time<\/b>: 26\/01\/2018 2:30:00 PM<\/p>

party<\/b>: Generated Summary: id: IPS-examples-Organization-01; 14999912399913; active; Hospital Municipal Hospital Doctor Ángel Pintos <\/a><\/p><\/blockquote>

custodian<\/b>: Generated Summary: id: IPS-examples-Organization-01; http://hospitalPintos.org.ar; active; name: Hospital Municipal Hospital Doctor Ángel Pintos \/ Dominio; ph: +54 02281 43-5200(WORK)<\/a><\/p><\/div>" 132 | }, 133 | "custodian" : { 134 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Organization\/IPS-examples-Organization-01" 135 | }, 136 | "attester" : [ 137 | { 138 | "mode" : "legal", 139 | "time" : "2018-01-26T14:30:00-03:00", 140 | "party" : { 141 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Organization\/IPS-examples-Organization-01" 142 | } 143 | } 144 | ], 145 | "status" : "final" 146 | } 147 | }, 148 | { 149 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/Patient\/IPS-examples-Patient-01", 150 | "resource" : { 151 | "id" : "IPS-examples-Patient-01", 152 | "gender" : "female", 153 | "telecom" : [ 154 | { 155 | "system" : "phone", 156 | "value" : "44318113" 157 | } 158 | ], 159 | "birthDate" : "1969-11-01", 160 | "identifier" : [ 161 | { 162 | "system" : "http://hospitalPintos.org.ar/Patient", 163 | "value" : "9000022" 164 | }, 165 | { 166 | "system" : "http:\/\/www.renaper.gob.ar\/dni", 167 | "value" : "99999999" 168 | } 169 | ], 170 | "resourceType" : "Patient", 171 | "active" : "true", 172 | "name" : [ 173 | { 174 | "family" : "Villareal", 175 | "given" : [ 176 | "Maria","Victoria" 177 | ], 178 | "_family" : { 179 | "extension" : [ 180 | { 181 | "url":"https://federador.msal.gob.ar/primer_apellido", 182 | "valueString":"Villareal" 183 | } 184 | ] 185 | }, 186 | "text" : "Villareal Maria Victoria" 187 | } 188 | ] 189 | } 190 | }, 191 | { 192 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/Device\/IPS-examples-Device-01", 193 | "resource" : { 194 | "resourceType" : "Device", 195 | "id" : "IPS-examples-Device-01", 196 | "identifier" : [ 197 | { 198 | "system" : "http://hospitalPintos.org.ar/Device", 199 | "value" : "HCE_HtalPintos_v1.0" 200 | } 201 | ], 202 | "type" : { 203 | "coding" :[ 204 | { 205 | "system": "http://snomed.info/sct", 206 | "code": "462894001", 207 | "display":"software de aplicación de sistema de información de historias clínicas de pacientes (objeto físico)" 208 | } 209 | ] 210 | }, 211 | "owner": { 212 | "reference": "http://argentina.gob.ar/salud/refes/Organization/14999912399913" 213 | }, 214 | "deviceName": [ 215 | { 216 | "name": "Sistema HCE del Hospital Municipal Dr Angel Pintos", 217 | "type": "manufacturer-name" 218 | } 219 | ] 220 | } 221 | }, 222 | { 223 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/Organization\/IPS-examples-Organization-01", 224 | "resource" : { 225 | "active" : true, 226 | "address" : [ 227 | { 228 | "use" : "work", 229 | "line" : [ 230 | "Amado Diab 270," 231 | ], 232 | "country" : "Argentina", 233 | "city" : "Azul", 234 | "postalCode" : "B7300" 235 | } 236 | ], 237 | "id" : "IPS-examples-Organization-01", 238 | "telecom" : [ 239 | { 240 | "system" : "phone", 241 | "value" : "+54 02281 43-5200", 242 | "use" : "work" 243 | } 244 | ], 245 | "text" : { 246 | "status" : "generated", 247 | "div" : "

Generated Narrative with Details<\/b><\/p>

id<\/b>: IPS-examples-Organization-01<\/p>

text<\/b>: <\/p>

identifier<\/b>: 14999912399913<\/p>

active<\/b>: true<\/p>

name<\/b>: Hospital Municipal Hospital Doctor Ángel Pintos<\/p>

telecom<\/b>: ph: +54 02281 43-5200<\/p>

address<\/b>: Amado Diab 270, B7300 Azul, Buenos Aires, Argentina<\/p><\/div>" 248 | }, 249 | "identifier" : [ 250 | { 251 | "system" : "http://argentina.gob.ar/salud/refes", 252 | "value" : "14999912399913" 253 | }, 254 | { 255 | "system" : "http://argentina.gob.ar/salud/bus-interoperabilidad/dominio", 256 | "value" : "http://hospitalPintos.org.ar" 257 | } 258 | ], 259 | "resourceType" : "Organization", 260 | "name" : "Hospital Municipal Hospital Doctor Ángel Pintos" 261 | } 262 | }, 263 | { 264 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/Condition\/IPS-examples-Condition-01", 265 | "resource" : { 266 | "id" : "IPS-examples-Condition-01", 267 | "category" : [ 268 | { 269 | "coding" : [ 270 | { 271 | "system" : "http:\/\/loinc.org", 272 | "display" : "Problem", 273 | "code" : "75326-9" 274 | } 275 | ] 276 | } 277 | ], 278 | "subject" : { 279 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Patient\/IPS-examples-Patient-01" 280 | }, 281 | "onsetDateTime" : "2016", 282 | "resourceType" : "Condition", 283 | "verificationStatus" : { 284 | "coding" : [ 285 | { 286 | "system" : "http:\/\/terminology.hl7.org\/CodeSystem\/condition-ver-status", 287 | "code" : "confirmed" 288 | } 289 | ] 290 | }, 291 | "code" : { 292 | "coding" : [ 293 | { 294 | "code" : "195967001", 295 | "system" : "http:\/\/snomed.info\/sct", 296 | "display" : "asma (trastorno)" 297 | } 298 | ] 299 | }, 300 | "recordedDate" : "2016-10", 301 | "meta" : { 302 | "profile" : [ 303 | "http:\/\/hl7.org\/fhir\/uv\/ips\/StructureDefinition\/condition-uv-ips" 304 | ] 305 | }, 306 | "text" : { 307 | "status" : "generated", 308 | "div" : "

Generated Narrative with Details<\/b><\/p>

id<\/b>: IPS-examples-Condition-01<\/p>

meta<\/b>: <\/p>

text<\/b>: <\/p>

identifier<\/b>: c87bf51c-e53c-4bfe-b8b7-aa62bdd93002<\/p>

clinicalStatus<\/b>: Active (Details : {http:\/\/terminology.hl7.org\/CodeSystem\/condition-clinical code 'active' = 'Active)<\/span><\/p>

verificationStatus<\/b>: Confirmed (Details : {http:\/\/terminology.hl7.org\/CodeSystem\/condition-ver-status code 'confirmed' = 'Confirmed)<\/span><\/p>

category<\/b>: Problem (Details : {LOINC code '75326-9' = 'Problem', given as 'Problem'})<\/span><\/p>

severity<\/b>: Moderate (Details : {LOINC code 'LA6751-7' = 'LA6751-7', given as 'Moderate'})<\/span><\/p>

code<\/b>: Menopausal flushing (finding) (Details : {SNOMED CT code '198436008' = 'Hot flush', given as 'Menopausal flushing (finding)'})<\/span><\/p>

subject<\/b>: Generated Summary: id: IPS-examples-Patient-01; 574687583; active; Martha DeLarosa ; ph: +31788700800(HOME); FEMALE; birthDate: 01\/05\/1972<\/a><\/p>

recordedDate<\/b>: 01\/10\/2016<\/p><\/div>" 309 | }, 310 | "severity" : { 311 | "coding" : [ 312 | { 313 | "system" : "http:\/\/loinc.org", 314 | "display" : "Moderate", 315 | "code" : "LA6751-7" 316 | } 317 | ] 318 | }, 319 | "clinicalStatus" : { 320 | "coding" : [ 321 | { 322 | "system" : "http:\/\/terminology.hl7.org\/CodeSystem\/condition-clinical", 323 | "code" : "active" 324 | } 325 | ] 326 | } 327 | } 328 | }, 329 | { 330 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/MedicationStatement\/IPS-examples-MedicationStatement-01", 331 | "resource" : { 332 | "status" : "active", 333 | "medicationReference" : { 334 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Medication\/IPS-examples-Medication-01" 335 | }, 336 | "dosage" : [ 337 | { 338 | "route" : { 339 | "coding" : [ 340 | { 341 | "system" : "http://snomed.info/sct", 342 | "display" : "vía de administración en el tracto respiratorio (calificador)", 343 | "code" : "447694001" 344 | } 345 | ] 346 | }, 347 | "timing" : { 348 | "repeat" : { 349 | "count" : 1, 350 | "periodUnit" : "d" 351 | } 352 | }, 353 | "doseAndRate" : [ 354 | { 355 | "type" : { 356 | "coding" : [ 357 | { 358 | "system" : "http:\/\/terminology.hl7.org\/CodeSystem\/dose-rate-type", 359 | "display" : "Ordered", 360 | "code" : "ordered" 361 | } 362 | ] 363 | }, 364 | "doseQuantity" : { 365 | "code" : "732981002", 366 | "value" : 1, 367 | "system" : "http://snomed.info/sct", 368 | "unit" : "disparo (unidad de presentación)" 369 | } 370 | } 371 | ] 372 | } 373 | ], 374 | "id" : "IPS-examples-MedicationStatement-01", 375 | "effectivePeriod" : { 376 | "start" : "2015-03" 377 | }, 378 | "subject" : { 379 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Patient\/IPS-examples-Patient-01" 380 | }, 381 | "meta" : { 382 | "profile" : [ 383 | "http:\/\/hl7.org\/fhir\/uv\/ips\/StructureDefinition\/medicationstatement-uv-ips" 384 | ] 385 | }, 386 | "text" : { 387 | "status" : "generated", 388 | "div" : "

Generated Narrative with Details<\/b><\/p>

id<\/b>: IPS-examples-MedicationStatement-01<\/p>

meta<\/b>: <\/p>

text<\/b>: <\/p>

identifier<\/b>: b75f92cb-61d4-469a-9387-df5ef70d25f0<\/p>

status<\/b>: ACTIVE<\/p>

medication<\/b>: Generated Summary: id: IPS-examples-Medication-01; Anastrozole (product)<\/span><\/a><\/p>

subject<\/b>: Generated Summary: id: IPS-examples-Patient-01; 574687583; active; Martha DeLarosa ; ph: +31788700800(HOME); FEMALE; birthDate: 01\/05\/1972<\/a><\/p>

effective<\/b>: 01\/03\/2015 --> (ongoing)<\/p>

dosage<\/b>: <\/p><\/div>" 389 | }, 390 | "resourceType" : "MedicationStatement" 391 | } 392 | }, 393 | { 394 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/Medication\/IPS-examples-Medication-01", 395 | "resource" : { 396 | "code" : { 397 | "coding" : [ 398 | { 399 | "system" : "http:\/\/snomed.info\/sct", 400 | "display" : "producto que contiene exactamente salbutamol 200 microgramos/disparo en polvo de liberación convencional para administración por inhalación (fármaco de uso clínico)", 401 | "code" : "770301006" 402 | } 403 | ] 404 | }, 405 | "form": { 406 | "coding" : [ 407 | { 408 | "system" : "http:\/\/snomed.info\/sct", 409 | "display" : "disparo (unidad de presentación)", 410 | "code" : "732981002" 411 | } 412 | ] 413 | }, 414 | "ingredient" : [ 415 | { 416 | "code": { 417 | "coding" : [ 418 | { 419 | "system" : "http:\/\/snomed.info\/sct", 420 | "display" : "salbutamol (sustancia)", 421 | "code" : "372897005" 422 | } 423 | ] 424 | }, 425 | "isActive" : true, 426 | "strength" : { 427 | "numerator" : { "value": 200, "unit" : "mcg" }, 428 | "denominator" : { "value": 1, "unit": "disparo" } 429 | } 430 | } 431 | ], 432 | "id" : "IPS-examples-Medication-01", 433 | "resourceType" : "Medication", 434 | "meta" : { 435 | "profile" : [ 436 | "http:\/\/hl7.org\/fhir\/uv\/ips\/StructureDefinition\/medication-uv-ips" 437 | ] 438 | }, 439 | "text" : { 440 | "status" : "generated", 441 | "div" : "

Generated Narrative with Details<\/b><\/p>

id<\/b>: IPS-examples-Medication-01<\/p>

meta<\/b>: <\/p>

text<\/b>: <\/p>

code<\/b>: producto que contiene exactamente salbutamol 200 microgramos/disparo en polvo de liberación convencional para administración por inhalación (fármaco de uso clínico) (Details : {SNOMED CT code '770301006' = 'producto que contiene exactamente salbutamol 200 microgramos/disparo en polvo de liberación convencional para administración por inhalación (fármaco de uso clínico)', given as 'Anastrozole (product)'};<\/span><\/p><\/div>" 442 | } 443 | } 444 | }, 445 | { 446 | "fullUrl" : "http:\/\/hapi.fhir.org\/baseR4\/AllergyIntolerance\/IPS-examples-AllergyIntolerance-01", 447 | "resource" : { 448 | "category" : [ 449 | "medication" 450 | ], 451 | "criticality" : "high", 452 | "patient" : { 453 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Patient\/IPS-examples-Patient-01" 454 | }, 455 | "id" : "IPS-examples-AllergyIntolerance-01", 456 | "code" : { 457 | "coding" : [ 458 | { 459 | "system" : "http:\/\/snomed.info\/sct", 460 | "display" : "alergia a la penicilina (trastorno)", 461 | "code" : "91936005" 462 | } 463 | ] 464 | }, 465 | "meta" : { 466 | "profile" : [ 467 | "http:\/\/hl7.org\/fhir\/uv\/ips\/StructureDefinition\/allergyintolerance-uv-ips" 468 | ] 469 | }, 470 | "text" : { 471 | "status" : "generated", 472 | "div" : "

Generated Narrative with Details<\/b><\/p>

id<\/b>: IPS-examples-AllergyIntolerance-01<\/p>

meta<\/b>: <\/p>

text<\/b>: <\/p>

identifier<\/b>: 3a462598-009c-484a-965c-d6b24a821424<\/p>

type<\/b>: ALLERGY<\/p>

category<\/b>: MEDICATION<\/p>

criticality<\/b>: HIGH<\/p>

code<\/b>: Penicillin -class of antibiotic- (substance) (Details : {SNOMED CT code '373270004' = 'Penicillin -class of antibiotic- (substance)', given as 'Penicillin -class of antibiotic- (substance)'})<\/span><\/p>

patient<\/b>: Generated Summary: id: IPS-examples-Patient-01; 574687583; active; Martha DeLarosa ; ph: +31788700800(HOME); FEMALE; birthDate: 01\/05\/1972<\/a><\/p><\/div>" 473 | }, 474 | "resourceType" : "AllergyIntolerance", 475 | "type" : "allergy", 476 | "onsetDateTime" : "2010" 477 | } 478 | }, 479 | { 480 | "fullUrl": "http:\/\/hapi.fhir.org\/baseR4\/Immunization\/IPS-examples-Immunization-01", 481 | "resource": { 482 | "resourceType": "Immunization", 483 | "id": "IPS-examples-Immunization-01", 484 | "status": "completed", 485 | "notGiven": false, 486 | "vaccineCode": { 487 | "coding": [ 488 | { 489 | "system": "https://snomed.info/sct/11000221109/id/228100022110", 490 | "code": "1181000221105", 491 | "display": "producto que contiene solamente antígeno de virus de la influenza (producto medicinal)" 492 | } 493 | ] 494 | }, 495 | "patient" : { 496 | "reference" : "http:\/\/hapi.fhir.org\/baseR4\/Patient\/IPS-examples-Patient-01" 497 | }, 498 | "occurrenceDateTime": "2017-05-22", 499 | "primarySource": true, 500 | "location": { 501 | "reference": "http://argentina.gob.ar/salud/refes/Location/14999912399913" 502 | }, 503 | "lotNumber": "649718", 504 | "expirationDate": "2017-12-22", 505 | "reasonCode": [ 506 | { 507 | "coding": [ 508 | { 509 | "system": "http://snomed.info/sct", 510 | "code": "429060002", 511 | "display": "procedimiento para cumplir con el requerimiento ocupacional (procedimiento)" 512 | }, 513 | { 514 | "system": "http://saluddigital.ar/valueSet/NOMIVAC-condicion-code", 515 | "code": "17", 516 | "display":"Personal de Salud" 517 | } 518 | ] 519 | } 520 | ], 521 | "isSubpotent": false, 522 | "protocolApplied": [ 523 | { 524 | "series": "Antigripal Esquema Personal de Salud", 525 | "extension": [ 526 | { 527 | "url":"http://saluddigital.ar/fhir/esquema", 528 | "valueCoding":{ 529 | "system":"http://saluddigital.ar/valueSet/NOMIVAC-esquema-code", 530 | "code":"81", 531 | "display":"Antigripal Esquema Personal de Salud" 532 | } 533 | } 534 | ], 535 | "targetDisease": [ 536 | { 537 | "coding": [ 538 | { 539 | "system": "http://snomed.info/sct", 540 | "code": "6142004", 541 | "display": "gripe (trastorno)" 542 | } 543 | ] 544 | } 545 | ], 546 | "doseNumberPositiveInt": 1 547 | } 548 | ] 549 | } 550 | } 551 | ], 552 | "type" : "document", 553 | "identifier" : { 554 | "system" : "http://hospitalPintos.org.ar/Bundle", 555 | "value" : "12000345" 556 | } 557 | } 558 | -------------------------------------------------------------------------------- /ips-example-bundle.json: -------------------------------------------------------------------------------- 1 | { 2 | "resourceType": "Bundle", 3 | "id": "IPS-examples-Bundle-01", 4 | "meta": { 5 | "lastUpdated": "2017-07-20T14:30:00+01:00" 6 | }, 7 | "language": "en-GB", 8 | "identifier": { 9 | "system": "urn:oid:2.16.724.4.8.10.200.10", 10 | "value": "175bd032-8b00-4728-b2dc-748bb1501aed" 11 | }, 12 | "type": "document", 13 | "entry": [ 14 | { 15 | "fullUrl": "http://hapi.fhir.org/baseR4/Composition/IPS-examples-Composition-01", 16 | "resource": { 17 | "resourceType": "Composition", 18 | "id": "IPS-examples-Composition-01", 19 | "meta": { 20 | "profile": [ 21 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Composition-uv-ips" 22 | ] 23 | }, 24 | "text": { 25 | "status": "generated", 26 | "div": "

Generated Narrative with Details

id: IPS-examples-Composition-01

meta:

identifier: 3f69e0a5-2177-4540-baab-7a5d0877428f

status: final

type: Patient summary Document (Details : {LOINC code '60591-5' = 'Patient summary Document', given as 'Patient summary Document'})

date: Jul 20, 2017 2:30:00 PM

author: http://hapi.fhir.org/baseR4/Practitioner/IPS-examples-Practitioner-01

title: Patient Summary as of July 20, 2017 14:30

confidentiality: N

attester

mode: legal

time: Jul 20, 2017 2:30:00 PM

party: http://hapi.fhir.org/baseR4/Practitioner/IPS-examples-Practitioner-01

attester

mode: legal

time: Jul 20, 2017 2:30:00 PM

party: http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-01

custodian: http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-01

RelatesTos

-CodeTarget[x]
*appendsc2277753-9f90-4a95-8ddb-a0b3f6e7d292

Events

-CodePeriod
*care provision (Details : {http://terminology.hl7.org/CodeSystem/v3-ActClass code 'PCPR' = 'care provision)?? --> Jul 20, 2017 2:30:00 PM
" 27 | }, 28 | "identifier": { 29 | "system": "urn:oid:2.16.724.4.8.10.200.10", 30 | "value": "3f69e0a5-2177-4540-baab-7a5d0877428f" 31 | }, 32 | "status": "final", 33 | "type": { 34 | "coding": [ 35 | { 36 | "system": "http://loinc.org", 37 | "code": "60591-5", 38 | "display": "Patient summary Document" 39 | } 40 | ] 41 | }, 42 | "subject": { 43 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 44 | }, 45 | "date": "2017-07-20T14:30:00+01:00", 46 | "author": [ 47 | { 48 | "reference": "http://hapi.fhir.org/baseR4/Practitioner/IPS-examples-Practitioner-01" 49 | } 50 | ], 51 | "title": "Patient Summary as of July 20, 2017 14:30", 52 | "confidentiality": "N", 53 | "attester": [ 54 | { 55 | "mode": "legal", 56 | "time": "2017-07-20T14:30:00+01:00", 57 | "party": { 58 | "reference": "http://hapi.fhir.org/baseR4/Practitioner/IPS-examples-Practitioner-01" 59 | } 60 | }, 61 | { 62 | "mode": "legal", 63 | "time": "2017-07-20T14:30:00+01:00", 64 | "party": { 65 | "reference": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-01" 66 | } 67 | } 68 | ], 69 | "custodian": { 70 | "reference": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-01" 71 | }, 72 | "relatesTo": [ 73 | { 74 | "code": "appends", 75 | "targetIdentifier": { 76 | "system": "urn:oid:2.16.724.4.8.10.200.10", 77 | "value": "c2277753-9f90-4a95-8ddb-a0b3f6e7d292" 78 | } 79 | } 80 | ], 81 | "event": [ 82 | { 83 | "code": [ 84 | { 85 | "coding": [ 86 | { 87 | "system": "http://terminology.hl7.org/CodeSystem/v3-ActClass", 88 | "code": "PCPR" 89 | } 90 | ] 91 | } 92 | ], 93 | "period": { 94 | "end": "2017-07-20T14:30:00+01:00" 95 | } 96 | } 97 | ], 98 | "section": [ 99 | { 100 | "title": "Active Problems", 101 | "code": { 102 | "coding": [ 103 | { 104 | "system": "http://loinc.org", 105 | "code": "11450-4", 106 | "display": "Problem list Reported" 107 | } 108 | ] 109 | }, 110 | "text": { 111 | "status": "generated", 112 | "div": "
Hot flushes
" 113 | }, 114 | "entry": [ 115 | { 116 | "reference": "http://hapi.fhir.org/baseR4/Condition/IPS-examples-Condition-01" 117 | } 118 | ] 119 | }, 120 | { 121 | "title": "Medication", 122 | "code": { 123 | "coding": [ 124 | { 125 | "system": "http://loinc.org", 126 | "code": "10160-0", 127 | "display": "History of Medication use Narrative" 128 | } 129 | ] 130 | }, 131 | "text": { 132 | "status": "generated", 133 | "div": "
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t
MedicationStrengthFormDosageComment
Anastrozole1 mgtabletonce dailytreatment for breast cancer
Black Cohosh Extract pil herbal supplement
\n\t\t\t\t\t\t
" 134 | }, 135 | "entry": [ 136 | { 137 | "reference": "http://hapi.fhir.org/baseR4/MedicationStatement/IPS-examples-MedicationStatement-01" 138 | }, 139 | { 140 | "reference": "http://hapi.fhir.org/baseR4/MedicationStatement/IPS-examples-MedicationStatement-02" 141 | } 142 | ] 143 | }, 144 | { 145 | "title": "Allergies and Intolerances", 146 | "code": { 147 | "coding": [ 148 | { 149 | "system": "http://loinc.org", 150 | "code": "48765-2", 151 | "display": "Allergies and adverse reactions Document" 152 | } 153 | ] 154 | }, 155 | "text": { 156 | "status": "generated", 157 | "div": "
Allergy to penicillin, high criticality, active\n\t\t\t\t\t\t\tNo known food allergies\n\t\t\t\t\t\t
" 158 | }, 159 | "entry": [ 160 | { 161 | "reference": "http://hapi.fhir.org/baseR4/AllergyIntolerance/IPS-examples-AllergyIntolerance-01" 162 | }, 163 | { 164 | "reference": "http://hapi.fhir.org/baseR4/AllergyIntolerance/IPS-examples-AllergyIntolerance-02" 165 | } 166 | ] 167 | }, 168 | { 169 | "title": "History of Past Illness", 170 | "code": { 171 | "coding": [ 172 | { 173 | "system": "http://loinc.org", 174 | "code": "11348-0", 175 | "display": "Hx of Past illness" 176 | } 177 | ] 178 | }, 179 | "text": { 180 | "status": "generated", 181 | "div": "
Breast cancer Stage II with no evidence of recurrence following treatment
" 182 | }, 183 | "entry": [ 184 | { 185 | "reference": "http://hapi.fhir.org/baseR4/Condition/IPS-examples-Condition-02" 186 | } 187 | ] 188 | }, 189 | { 190 | "title": "Plan of Treatment", 191 | "code": { 192 | "coding": [ 193 | { 194 | "system": "http://loinc.org", 195 | "code": "18776-5", 196 | "display": "Plan of care note" 197 | } 198 | ] 199 | }, 200 | "text": { 201 | "status": "generated", 202 | "div": "
Continue hormone medication with Anastrozole for total of 5 years and monitor for potential breast cancer recurrence
" 203 | } 204 | }, 205 | { 206 | "title": "Results", 207 | "code": { 208 | "coding": [ 209 | { 210 | "system": "http://loinc.org", 211 | "code": "30954-2", 212 | "display": "Relevant diagnostic tests/laboratory data Narrative" 213 | } 214 | ] 215 | }, 216 | "text": { 217 | "status": "generated", 218 | "div": "
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t
Blood typing
Blood groupA+\n\t\t\t\t\t\t\t\t\t
C Ab [Presence] in Serum or PlasmaPositive\n\t\t\t\t\t\t\t\t\t
E Ab [Presence] in Serum or PlasmaPositive\n\t\t\t\t\t\t\t\t\t
Little c Ab [Presence] in Serum or PlasmaNegative\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t
Hemoglobin A1c monitoring
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC7.5 %\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t
Bacteriology
Methicillin resistant Staphylococcus aureus
Healthy carrier of MRSA
\n\t\t\t\t\t\t
" 219 | }, 220 | "entry": [ 221 | { 222 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub0" 223 | }, 224 | { 225 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub1" 226 | }, 227 | { 228 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub2" 229 | }, 230 | { 231 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub3" 232 | }, 233 | { 234 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-0" 235 | }, 236 | { 237 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-1" 238 | }, 239 | { 240 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-3" 241 | } 242 | ] 243 | } 244 | ] 245 | } 246 | }, 247 | { 248 | "fullUrl": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01", 249 | "resource": { 250 | "resourceType": "Patient", 251 | "id": "IPS-examples-Patient-01", 252 | "meta": { 253 | "profile": [ 254 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Patient-uv-ips" 255 | ] 256 | }, 257 | "text": { 258 | "status": "generated", 259 | "div": "

Generated Narrative with Details

id: IPS-examples-Patient-01

meta:

identifier: 574687583

active: true

name: Martha DeLarosa

telecom: ph: +31788700800(HOME)

gender: female

birthDate: May 1, 1972

address: Laan Van Europa 1600 Dordrecht 3317 DB Netherlands

Contacts

-RelationshipNameTelecomAddress
*mother (Details : {http://terminology.hl7.org/CodeSystem/v3-RoleCode code 'MTH' = 'mother)Martha Mum ph: +33-555-20036(HOME)Promenade des Anglais 111 Lyon 69001 France
" 260 | }, 261 | "identifier": [ 262 | { 263 | "system": "urn:oid:2.16.840.1.113883.2.4.6.3", 264 | "value": "574687583" 265 | } 266 | ], 267 | "active": true, 268 | "name": [ 269 | { 270 | "family": "DeLarosa", 271 | "given": [ 272 | "Martha" 273 | ] 274 | } 275 | ], 276 | "telecom": [ 277 | { 278 | "system": "phone", 279 | "value": "+31788700800", 280 | "use": "home" 281 | } 282 | ], 283 | "gender": "female", 284 | "birthDate": "1972-05-01", 285 | "address": [ 286 | { 287 | "line": [ 288 | "Laan Van Europa 1600" 289 | ], 290 | "city": "Dordrecht", 291 | "postalCode": "3317 DB", 292 | "country": "Netherlands" 293 | } 294 | ], 295 | "contact": [ 296 | { 297 | "relationship": [ 298 | { 299 | "coding": [ 300 | { 301 | "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode", 302 | "code": "MTH" 303 | } 304 | ] 305 | } 306 | ], 307 | "name": { 308 | "family": "Mum", 309 | "given": [ 310 | "Martha" 311 | ] 312 | }, 313 | "telecom": [ 314 | { 315 | "system": "phone", 316 | "value": "+33-555-20036", 317 | "use": "home" 318 | } 319 | ], 320 | "address": { 321 | "line": [ 322 | "Promenade des Anglais 111" 323 | ], 324 | "city": "Lyon", 325 | "postalCode": "69001", 326 | "country": "France" 327 | } 328 | } 329 | ] 330 | } 331 | }, 332 | { 333 | "fullUrl": "http://hapi.fhir.org/baseR4/Practitioner/IPS-examples-Practitioner-01", 334 | "resource": { 335 | "resourceType": "Practitioner", 336 | "id": "IPS-examples-Practitioner-01", 337 | "text": { 338 | "status": "generated", 339 | "div": "

Generated Narrative with Details

id: IPS-examples-Practitioner-01

identifier: 129854633

active: true

name: Beetje van Hulp

Qualifications

-Code
*Generalist medical practitioners (Details : {urn:oid:2.16.840.1.113883.2.9.6.2.7 code '2211' = '2211', given as 'Generalist medical practitioners'}; {urn:oid:2.16.840.1.113883.2.4.15.111 code '01.015' = '01.015', given as 'Huisarts'})
" 340 | }, 341 | "identifier": [ 342 | { 343 | "system": "urn:oid:2.16.528.1.1007.3.1", 344 | "value": "129854633", 345 | "assigner": { 346 | "display": "CIBG" 347 | } 348 | } 349 | ], 350 | "active": true, 351 | "name": [ 352 | { 353 | "family": "van Hulp", 354 | "given": [ 355 | "Beetje" 356 | ] 357 | } 358 | ], 359 | "qualification": [ 360 | { 361 | "code": { 362 | "coding": [ 363 | { 364 | "system": "urn:oid:2.16.840.1.113883.2.9.6.2.7", 365 | "code": "2211", 366 | "display": "Generalist medical practitioners" 367 | }, 368 | { 369 | "system": "urn:oid:2.16.840.1.113883.2.4.15.111", 370 | "code": "01.015", 371 | "display": "Huisarts" 372 | } 373 | ] 374 | } 375 | } 376 | ] 377 | } 378 | }, 379 | { 380 | "fullUrl": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-01", 381 | "resource": { 382 | "resourceType": "Organization", 383 | "id": "IPS-examples-Organization-01", 384 | "text": { 385 | "status": "generated", 386 | "div": "

Generated Narrative with Details

id: IPS-examples-Organization-01

identifier: 564738757

active: true

name: Anorg Aniza Tion BV / The best custodian ever

telecom: ph: +31-51-34343400(WORK)

address: Houttuinen 27 Dordrecht 3311 CE Netherlands (WORK)

" 387 | }, 388 | "identifier": [ 389 | { 390 | "system": "urn:oid:2.16.528.1.1007.3.3", 391 | "value": "564738757" 392 | } 393 | ], 394 | "active": true, 395 | "name": "Anorg Aniza Tion BV / The best custodian ever", 396 | "telecom": [ 397 | { 398 | "system": "phone", 399 | "value": "+31-51-34343400", 400 | "use": "work" 401 | } 402 | ], 403 | "address": [ 404 | { 405 | "use": "work", 406 | "line": [ 407 | "Houttuinen 27" 408 | ], 409 | "city": "Dordrecht", 410 | "postalCode": "3311 CE", 411 | "country": "Netherlands" 412 | } 413 | ] 414 | } 415 | }, 416 | { 417 | "fullUrl": "http://hapi.fhir.org/baseR4/Condition/IPS-examples-Condition-01", 418 | "resource": { 419 | "resourceType": "Condition", 420 | "id": "IPS-examples-Condition-01", 421 | "meta": { 422 | "profile": [ 423 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips" 424 | ] 425 | }, 426 | "text": { 427 | "status": "generated", 428 | "div": "

Generated Narrative with Details

id: IPS-examples-Condition-01

meta:

identifier: c87bf51c-e53c-4bfe-b8b7-aa62bdd93002

clinicalStatus: Active (Details : {http://terminology.hl7.org/CodeSystem/condition-clinical code 'active' = 'Active)

verificationStatus: Confirmed (Details : {http://terminology.hl7.org/CodeSystem/condition-ver-status code 'confirmed' = 'Confirmed)

category: Problem (Details : {LOINC code '75326-9' = 'Problem', given as 'Problem'})

severity: Moderate (Details : {LOINC code 'LA6751-7' = 'Moderate', given as 'Moderate'})

code: Menopausal flushing (finding) (Details : {SNOMED CT code '198436008' = 'Hot flush', given as 'Menopausal flushing (finding)'}; {http://hl7.org/fhir/sid/icd-10 code 'N95.1' = 'N95.1', given as 'Menopausal and female climacteric states'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

onset: Jan 1, 2015

recordedDate: Oct 1, 2016

" 429 | }, 430 | "identifier": [ 431 | { 432 | "system": "urn:oid:1.2.3.999", 433 | "value": "c87bf51c-e53c-4bfe-b8b7-aa62bdd93002" 434 | } 435 | ], 436 | "clinicalStatus": { 437 | "coding": [ 438 | { 439 | "system": "http://terminology.hl7.org/CodeSystem/condition-clinical", 440 | "code": "active" 441 | } 442 | ] 443 | }, 444 | "verificationStatus": { 445 | "coding": [ 446 | { 447 | "system": "http://terminology.hl7.org/CodeSystem/condition-ver-status", 448 | "code": "confirmed" 449 | } 450 | ] 451 | }, 452 | "category": [ 453 | { 454 | "coding": [ 455 | { 456 | "system": "http://loinc.org", 457 | "code": "75326-9", 458 | "display": "Problem" 459 | } 460 | ] 461 | } 462 | ], 463 | "severity": { 464 | "coding": [ 465 | { 466 | "system": "http://loinc.org", 467 | "code": "LA6751-7", 468 | "display": "Moderate" 469 | } 470 | ] 471 | }, 472 | "code": { 473 | "coding": [ 474 | { 475 | "extension": [ 476 | { 477 | "url": "http://hl7.org/fhir/StructureDefinition/translation", 478 | "extension": [ 479 | { 480 | "url": "lang", 481 | "valueCode": "nl-NL" 482 | }, 483 | { 484 | "url": "content", 485 | "valueString": "opvliegers" 486 | } 487 | ] 488 | } 489 | ], 490 | "system": "http://snomed.info/sct", 491 | "code": "198436008", 492 | "display": "Menopausal flushing (finding)" 493 | }, 494 | { 495 | "system": "http://hl7.org/fhir/sid/icd-10", 496 | "code": "N95.1", 497 | "display": "Menopausal and female climacteric states" 498 | } 499 | ] 500 | }, 501 | "subject": { 502 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 503 | }, 504 | "onsetDateTime": "2015", 505 | "recordedDate": "2016-10" 506 | } 507 | }, 508 | { 509 | "fullUrl": "http://hapi.fhir.org/baseR4/MedicationStatement/IPS-examples-MedicationStatement-01", 510 | "resource": { 511 | "resourceType": "MedicationStatement", 512 | "id": "IPS-examples-MedicationStatement-01", 513 | "meta": { 514 | "profile": [ 515 | "http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips" 516 | ] 517 | }, 518 | "text": { 519 | "status": "generated", 520 | "div": "

Generated Narrative with Details

id: IPS-examples-MedicationStatement-01

meta:

identifier: b75f92cb-61d4-469a-9387-df5ef70d25f0

status: active

medication: http://hapi.fhir.org/baseR4/Medication/IPS-examples-Medication-01

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Mar 1, 2015 --> (ongoing)

dosage:

" 521 | }, 522 | "identifier": [ 523 | { 524 | "system": "urn:oid:1.2.3.999", 525 | "value": "b75f92cb-61d4-469a-9387-df5ef70d25f0" 526 | } 527 | ], 528 | "status": "active", 529 | "medicationReference": { 530 | "reference": "http://hapi.fhir.org/baseR4/Medication/IPS-examples-Medication-01" 531 | }, 532 | "subject": { 533 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 534 | }, 535 | "effectivePeriod": { 536 | "start": "2015-03" 537 | }, 538 | "dosage": [ 539 | { 540 | "timing": { 541 | "repeat": { 542 | "count": 1, 543 | "periodUnit": "d" 544 | } 545 | }, 546 | "route": { 547 | "coding": [ 548 | { 549 | "system": "http://hl7.org/fhir/uv/ips/CodeSystem/edqm-uv-ips", 550 | "code": "20053000", 551 | "display": "Oral use" 552 | } 553 | ] 554 | }, 555 | "doseAndRate": [ 556 | { 557 | "type": { 558 | "coding": [ 559 | { 560 | "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", 561 | "code": "ordered", 562 | "display": "Ordered" 563 | } 564 | ] 565 | }, 566 | "doseQuantity": { 567 | "value": 1, 568 | "unit": "tablet", 569 | "system": "http://unitsofmeasure.org", 570 | "code": "1" 571 | } 572 | } 573 | ] 574 | } 575 | ] 576 | } 577 | }, 578 | { 579 | "fullUrl": "http://hapi.fhir.org/baseR4/MedicationStatement/IPS-examples-MedicationStatement-02", 580 | "resource": { 581 | "resourceType": "MedicationStatement", 582 | "id": "IPS-examples-MedicationStatement-02", 583 | "meta": { 584 | "profile": [ 585 | "http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips" 586 | ] 587 | }, 588 | "text": { 589 | "status": "generated", 590 | "div": "

Generated Narrative with Details

id: IPS-examples-MedicationStatement-02

meta:

identifier: 9e312d6b-c6b6-439a-a730-6efaa5dcf8bc

status: active

medication: http://hapi.fhir.org/baseR4/Medication/IPS-examples-Medication-02

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Jan 1, 2016 --> (ongoing)

dosage:

" 591 | }, 592 | "identifier": [ 593 | { 594 | "system": "urn:oid:1.2.3.999", 595 | "value": "9e312d6b-c6b6-439a-a730-6efaa5dcf8bc" 596 | } 597 | ], 598 | "status": "active", 599 | "medicationReference": { 600 | "reference": "http://hapi.fhir.org/baseR4/Medication/IPS-examples-Medication-02" 601 | }, 602 | "subject": { 603 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 604 | }, 605 | "effectivePeriod": { 606 | "start": "2016-01" 607 | }, 608 | "dosage": [ 609 | { 610 | "route": { 611 | "coding": [ 612 | { 613 | "system": "http://hl7.org/fhir/uv/ips/CodeSystem/edqm-uv-ips", 614 | "code": "20053000", 615 | "display": "Oral use" 616 | } 617 | ] 618 | } 619 | } 620 | ] 621 | } 622 | }, 623 | { 624 | "fullUrl": "http://hapi.fhir.org/baseR4/Medication/IPS-examples-Medication-01", 625 | "resource": { 626 | "resourceType": "Medication", 627 | "id": "IPS-examples-Medication-01", 628 | "meta": { 629 | "profile": [ 630 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips" 631 | ] 632 | }, 633 | "text": { 634 | "status": "generated", 635 | "div": "

Generated Narrative with Details

id: IPS-examples-Medication-01

meta:

code: Anastrozole (product) (Details : {SNOMED CT code '108774000' = 'Anastrozole (product)', given as 'Anastrozole (product)'}; {urn:oid:2.16.840.1.113883.2.4.4.1 code '99872' = '99872', given as 'ANASTROZOL 1MG TABLET'}; {urn:oid:2.16.840.1.113883.2.4.4.7 code '2076667' = '2076667', given as 'ANASTROZOL CF TABLET FILMOMHULD 1MG'})

" 636 | }, 637 | "code": { 638 | "coding": [ 639 | { 640 | "system": "http://snomed.info/sct", 641 | "code": "108774000", 642 | "display": "Anastrozole (product)" 643 | }, 644 | { 645 | "system": "urn:oid:2.16.840.1.113883.2.4.4.1", 646 | "code": "99872", 647 | "display": "ANASTROZOL 1MG TABLET" 648 | }, 649 | { 650 | "system": "urn:oid:2.16.840.1.113883.2.4.4.7", 651 | "code": "2076667", 652 | "display": "ANASTROZOL CF TABLET FILMOMHULD 1MG" 653 | } 654 | ] 655 | } 656 | } 657 | }, 658 | { 659 | "fullUrl": "http://hapi.fhir.org/baseR4/Medication/IPS-examples-Medication-02", 660 | "resource": { 661 | "resourceType": "Medication", 662 | "id": "IPS-examples-Medication-02", 663 | "meta": { 664 | "profile": [ 665 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips" 666 | ] 667 | }, 668 | "text": { 669 | "status": "generated", 670 | "div": "

Generated Narrative with Details

id: IPS-examples-Medication-02

meta:

code: Black Cohosh Extract herbal supplement (Details : {SNOMED CT code '412588001' = 'Cimicifuga racemosa extract (substance)', given as 'Cimicifuga racemosa extract (substance)'})

" 671 | }, 672 | "code": { 673 | "coding": [ 674 | { 675 | "extension": [ 676 | { 677 | "url": "http://hl7.org/fhir/StructureDefinition/translation", 678 | "extension": [ 679 | { 680 | "url": "lang", 681 | "valueCode": "nl-NL" 682 | }, 683 | { 684 | "url": "content", 685 | "valueString": "Zwarte Cohosh Extract" 686 | } 687 | ] 688 | } 689 | ], 690 | "system": "http://snomed.info/sct", 691 | "code": "412588001", 692 | "display": "Cimicifuga racemosa extract (substance)" 693 | } 694 | ], 695 | "text": "Black Cohosh Extract herbal supplement" 696 | } 697 | } 698 | }, 699 | { 700 | "fullUrl": "http://hapi.fhir.org/baseR4/AllergyIntolerance/IPS-examples-AllergyIntolerance-01", 701 | "resource": { 702 | "resourceType": "AllergyIntolerance", 703 | "id": "IPS-examples-AllergyIntolerance-01", 704 | "meta": { 705 | "profile": [ 706 | "http://hl7.org/fhir/uv/ips/StructureDefinition/AllergyIntolerance-uv-ips" 707 | ] 708 | }, 709 | "text": { 710 | "status": "generated", 711 | "div": "

Generated Narrative with Details

id: IPS-examples-AllergyIntolerance-01

meta:

identifier: 3a462598-009c-484a-965c-d6b24a821424

clinicalStatus: Active (Details : {http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical code 'active' = 'Active)

verificationStatus: Confirmed (Details : {http://terminology.hl7.org/CodeSystem/allergyintolerance-verification code 'confirmed' = 'Confirmed)

type: allergy

category: medication

criticality: high

code: Penicillin -class of antibiotic- (substance) (Details : {SNOMED CT code '373270004' = 'Penicillin -class of antibiotic- (substance)', given as 'Penicillin -class of antibiotic- (substance)'})

patient: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

onset: Jan 1, 2010

" 712 | }, 713 | "identifier": [ 714 | { 715 | "system": "urn:oid:1.2.3.999", 716 | "value": "3a462598-009c-484a-965c-d6b24a821424" 717 | } 718 | ], 719 | "clinicalStatus": { 720 | "coding": [ 721 | { 722 | "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical", 723 | "code": "active" 724 | } 725 | ] 726 | }, 727 | "verificationStatus": { 728 | "coding": [ 729 | { 730 | "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification", 731 | "code": "confirmed" 732 | } 733 | ] 734 | }, 735 | "type": "allergy", 736 | "category": [ 737 | "medication" 738 | ], 739 | "criticality": "high", 740 | "code": { 741 | "coding": [ 742 | { 743 | "system": "http://snomed.info/sct", 744 | "code": "373270004", 745 | "display": "Penicillin -class of antibiotic- (substance)" 746 | } 747 | ] 748 | }, 749 | "patient": { 750 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 751 | }, 752 | "onsetDateTime": "2010" 753 | } 754 | }, 755 | { 756 | "fullUrl": "http://hapi.fhir.org/baseR4/Condition/IPS-examples-Condition-02", 757 | "resource": { 758 | "resourceType": "Condition", 759 | "id": "IPS-examples-Condition-02", 760 | "meta": { 761 | "profile": [ 762 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips" 763 | ] 764 | }, 765 | "text": { 766 | "status": "generated", 767 | "div": "

Generated Narrative with Details

id: IPS-examples-Condition-02

meta:

identifier: 66d4a8c7-9081-43e0-a63f-489c2ae6edd6

clinicalStatus: Remission (Details : {http://terminology.hl7.org/CodeSystem/condition-clinical code 'remission' = 'Remission)

verificationStatus: Confirmed (Details : {http://terminology.hl7.org/CodeSystem/condition-ver-status code 'confirmed' = 'Confirmed)

category: Problem (Details : {LOINC code '75326-9' = 'Problem', given as 'Problem'})

severity: Severe (Details : {LOINC code 'LA6750-9' = 'Severe', given as 'Severe'})

code: Malignant tumor of breast (Details : {SNOMED CT code '254837009' = 'Malignant tumor of breast', given as 'Malignant tumor of breast'}; {urn:oid:2.16.840.1.113883.6.43 code '8500/3' = '8500/3', given as 'Infiltrating duct carcinoma, NOS'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

onset: Jan 1, 2015

abatement: Mar 1, 2015

" 768 | }, 769 | "identifier": [ 770 | { 771 | "system": "urn:oid:1.2.3.999", 772 | "value": "66d4a8c7-9081-43e0-a63f-489c2ae6edd6" 773 | } 774 | ], 775 | "clinicalStatus": { 776 | "coding": [ 777 | { 778 | "system": "http://terminology.hl7.org/CodeSystem/condition-clinical", 779 | "code": "remission" 780 | } 781 | ] 782 | }, 783 | "verificationStatus": { 784 | "coding": [ 785 | { 786 | "system": "http://terminology.hl7.org/CodeSystem/condition-ver-status", 787 | "code": "confirmed" 788 | } 789 | ] 790 | }, 791 | "category": [ 792 | { 793 | "coding": [ 794 | { 795 | "system": "http://loinc.org", 796 | "code": "75326-9", 797 | "display": "Problem" 798 | } 799 | ] 800 | } 801 | ], 802 | "severity": { 803 | "coding": [ 804 | { 805 | "system": "http://loinc.org", 806 | "code": "LA6750-9", 807 | "display": "Severe" 808 | } 809 | ] 810 | }, 811 | "code": { 812 | "coding": [ 813 | { 814 | "extension": [ 815 | { 816 | "url": "http://hl7.org/fhir/StructureDefinition/translation", 817 | "extension": [ 818 | { 819 | "url": "lang", 820 | "valueCode": "nl-NL" 821 | }, 822 | { 823 | "url": "content", 824 | "valueString": "Borstkanker stadium II zonder aanwijzingen van recidieven na behandeling" 825 | } 826 | ] 827 | } 828 | ], 829 | "system": "http://snomed.info/sct", 830 | "code": "254837009", 831 | "display": "Malignant tumor of breast" 832 | }, 833 | { 834 | "system": "urn:oid:2.16.840.1.113883.6.43", 835 | "code": "8500/3", 836 | "display": "Infiltrating duct carcinoma, NOS" 837 | } 838 | ] 839 | }, 840 | "subject": { 841 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 842 | }, 843 | "onsetDateTime": "2015-01", 844 | "abatementDateTime": "2015-03" 845 | } 846 | }, 847 | { 848 | "fullUrl": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02", 849 | "resource": { 850 | "resourceType": "Organization", 851 | "id": "IPS-examples-Organization-02", 852 | "text": { 853 | "status": "generated", 854 | "div": "

Generated Narrative with Details

id: IPS-examples-Organization-02

active: true

type: Other (Details : {http://terminology.hl7.org/CodeSystem/organization-type code 'other' = 'Other)

name: Laboratoire de charme

" 855 | }, 856 | "active": true, 857 | "type": [ 858 | { 859 | "coding": [ 860 | { 861 | "system": "http://terminology.hl7.org/CodeSystem/organization-type", 862 | "code": "other" 863 | } 864 | ] 865 | } 866 | ], 867 | "name": "Laboratoire de charme" 868 | } 869 | }, 870 | { 871 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub0", 872 | "resource": { 873 | "resourceType": "Observation", 874 | "id": "IPS-examples-Observation-01-Sub0", 875 | "meta": { 876 | "profile": [ 877 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-member-laboratory-uv-ips" 878 | ] 879 | }, 880 | "text": { 881 | "status": "generated", 882 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-Sub0

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: ABO and Rh group [Type] in Blood (Details : {LOINC code '882-1' = 'ABO and Rh group [Type] in Blood', given as 'ABO and Rh group [Type] in Blood'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Oct 10, 2015 9:15:00 AM

value: Blood group A Rh(D) positive (Details : {SNOMED CT code '278149003' = 'Blood group A Rh(D) positive', given as 'Blood group A Rh(D) positive'})

" 883 | }, 884 | "status": "final", 885 | "category": [ 886 | { 887 | "coding": [ 888 | { 889 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 890 | "code": "laboratory" 891 | } 892 | ] 893 | } 894 | ], 895 | "code": { 896 | "coding": [ 897 | { 898 | "system": "http://loinc.org", 899 | "code": "882-1", 900 | "display": "ABO and Rh group [Type] in Blood" 901 | } 902 | ] 903 | }, 904 | "subject": { 905 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 906 | }, 907 | "effectiveDateTime": "2015-10-10T09:15:00+01:00", 908 | "valueCodeableConcept": { 909 | "coding": [ 910 | { 911 | "system": "http://snomed.info/sct", 912 | "code": "278149003", 913 | "display": "Blood group A Rh(D) positive" 914 | } 915 | ] 916 | } 917 | } 918 | }, 919 | { 920 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub1", 921 | "resource": { 922 | "resourceType": "Observation", 923 | "id": "IPS-examples-Observation-01-Sub1", 924 | "meta": { 925 | "profile": [ 926 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-member-laboratory-uv-ips" 927 | ] 928 | }, 929 | "text": { 930 | "status": "generated", 931 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-Sub1

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: C Ab [Presence] in Serum or Plasma (Details : {LOINC code '945-6' = 'C Ab [Presence] in Serum or Plasma', given as 'C Ab [Presence] in Serum or Plasma'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Oct 10, 2015 9:35:00 AM

value: Positive (Details : {SNOMED CT code '10828004' = 'Positive', given as 'Positive'})

" 932 | }, 933 | "status": "final", 934 | "category": [ 935 | { 936 | "coding": [ 937 | { 938 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 939 | "code": "laboratory" 940 | } 941 | ] 942 | } 943 | ], 944 | "code": { 945 | "coding": [ 946 | { 947 | "system": "http://loinc.org", 948 | "code": "945-6", 949 | "display": "C Ab [Presence] in Serum or Plasma" 950 | } 951 | ] 952 | }, 953 | "subject": { 954 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 955 | }, 956 | "effectiveDateTime": "2015-10-10T09:35:00+01:00", 957 | "valueCodeableConcept": { 958 | "coding": [ 959 | { 960 | "system": "http://snomed.info/sct", 961 | "code": "10828004", 962 | "display": "Positive" 963 | } 964 | ] 965 | } 966 | } 967 | }, 968 | { 969 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub2", 970 | "resource": { 971 | "resourceType": "Observation", 972 | "id": "IPS-examples-Observation-01-Sub2", 973 | "meta": { 974 | "profile": [ 975 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-member-laboratory-uv-ips" 976 | ] 977 | }, 978 | "text": { 979 | "status": "generated", 980 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-Sub2

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: E Ab [Presence] in Serum or Plasma (Details : {LOINC code '1018-1' = 'E Ab [Presence] in Serum or Plasma', given as 'E Ab [Presence] in Serum or Plasma'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Oct 10, 2015 9:35:00 AM

value: Positive (Details : {SNOMED CT code '10828004' = 'Positive', given as 'Positive'})

" 981 | }, 982 | "status": "final", 983 | "category": [ 984 | { 985 | "coding": [ 986 | { 987 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 988 | "code": "laboratory" 989 | } 990 | ] 991 | } 992 | ], 993 | "code": { 994 | "coding": [ 995 | { 996 | "system": "http://loinc.org", 997 | "code": "1018-1", 998 | "display": "E Ab [Presence] in Serum or Plasma" 999 | } 1000 | ] 1001 | }, 1002 | "subject": { 1003 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 1004 | }, 1005 | "effectiveDateTime": "2015-10-10T09:35:00+01:00", 1006 | "valueCodeableConcept": { 1007 | "coding": [ 1008 | { 1009 | "system": "http://snomed.info/sct", 1010 | "code": "10828004", 1011 | "display": "Positive" 1012 | } 1013 | ] 1014 | } 1015 | } 1016 | }, 1017 | { 1018 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub3", 1019 | "resource": { 1020 | "resourceType": "Observation", 1021 | "id": "IPS-examples-Observation-01-Sub3", 1022 | "meta": { 1023 | "profile": [ 1024 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-member-laboratory-uv-ips" 1025 | ] 1026 | }, 1027 | "text": { 1028 | "status": "generated", 1029 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-Sub3

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: little c Ab [Presence] in Serum or Plasma (Details : {LOINC code '1156-9' = 'little c Ab [Presence] in Serum or Plasma', given as 'little c Ab [Presence] in Serum or Plasma'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Oct 10, 2015 9:35:00 AM

value: Negative (Details : {SNOMED CT code '260385009' = 'Negative', given as 'Negative'})

" 1030 | }, 1031 | "status": "final", 1032 | "category": [ 1033 | { 1034 | "coding": [ 1035 | { 1036 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 1037 | "code": "laboratory" 1038 | } 1039 | ] 1040 | } 1041 | ], 1042 | "code": { 1043 | "coding": [ 1044 | { 1045 | "system": "http://loinc.org", 1046 | "code": "1156-9", 1047 | "display": "little c Ab [Presence] in Serum or Plasma" 1048 | } 1049 | ] 1050 | }, 1051 | "subject": { 1052 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 1053 | }, 1054 | "effectiveDateTime": "2015-10-10T09:35:00+01:00", 1055 | "valueCodeableConcept": { 1056 | "coding": [ 1057 | { 1058 | "system": "http://snomed.info/sct", 1059 | "code": "260385009", 1060 | "display": "Negative" 1061 | } 1062 | ] 1063 | } 1064 | } 1065 | }, 1066 | { 1067 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-0", 1068 | "resource": { 1069 | "resourceType": "Observation", 1070 | "id": "IPS-examples-Observation-01-0", 1071 | "meta": { 1072 | "profile": [ 1073 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-laboratory-uv-ips" 1074 | ] 1075 | }, 1076 | "text": { 1077 | "status": "generated", 1078 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-0

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: Blood typing (Details )

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Oct 10, 2015

performer: http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02

hasMember:

" 1079 | }, 1080 | "status": "final", 1081 | "category": [ 1082 | { 1083 | "coding": [ 1084 | { 1085 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 1086 | "code": "laboratory" 1087 | } 1088 | ] 1089 | } 1090 | ], 1091 | "code": { 1092 | "text": "Blood typing" 1093 | }, 1094 | "subject": { 1095 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 1096 | }, 1097 | "effectiveDateTime": "2015-10-10", 1098 | "performer": [ 1099 | { 1100 | "reference": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02" 1101 | } 1102 | ], 1103 | "hasMember": [ 1104 | { 1105 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub0" 1106 | }, 1107 | { 1108 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub1" 1109 | }, 1110 | { 1111 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub2" 1112 | }, 1113 | { 1114 | "reference": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-Sub3" 1115 | } 1116 | ] 1117 | } 1118 | }, 1119 | { 1120 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-1", 1121 | "resource": { 1122 | "resourceType": "Observation", 1123 | "id": "IPS-examples-Observation-01-1", 1124 | "meta": { 1125 | "profile": [ 1126 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-laboratory-uv-ips" 1127 | ] 1128 | }, 1129 | "text": { 1130 | "status": "generated", 1131 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-1

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: Hemoglobin A1c/Hemoglobin.total in Blood by HPLC (Details : {LOINC code '17856-6' = 'Hemoglobin A1c/Hemoglobin.total in Blood by HPLC', given as 'Hemoglobin A1c/Hemoglobin.total in Blood by HPLC'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Nov 10, 2017 8:20:00 AM

performer: http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02

value: 7.5 % (Details: UCUM code % = '%')

note: Above stated goal of 7.0 %

" 1132 | }, 1133 | "status": "final", 1134 | "category": [ 1135 | { 1136 | "coding": [ 1137 | { 1138 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 1139 | "code": "laboratory" 1140 | } 1141 | ] 1142 | } 1143 | ], 1144 | "code": { 1145 | "coding": [ 1146 | { 1147 | "system": "http://loinc.org", 1148 | "code": "17856-6", 1149 | "display": "Hemoglobin A1c/Hemoglobin.total in Blood by HPLC" 1150 | } 1151 | ] 1152 | }, 1153 | "subject": { 1154 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 1155 | }, 1156 | "effectiveDateTime": "2017-11-10T08:20:00+01:00", 1157 | "performer": [ 1158 | { 1159 | "reference": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02" 1160 | } 1161 | ], 1162 | "valueQuantity": { 1163 | "value": 7.5, 1164 | "unit": "%", 1165 | "system": "http://unitsofmeasure.org", 1166 | "code": "%" 1167 | }, 1168 | "note": [ 1169 | { 1170 | "text": "Above stated goal of 7.0 %" 1171 | } 1172 | ] 1173 | } 1174 | }, 1175 | { 1176 | "fullUrl": "http://hapi.fhir.org/baseR4/Observation/IPS-examples-Observation-01-3", 1177 | "resource": { 1178 | "resourceType": "Observation", 1179 | "id": "IPS-examples-Observation-01-3", 1180 | "meta": { 1181 | "profile": [ 1182 | "http://hl7.org/fhir/uv/ips/StructureDefinition/Observation-laboratory-uv-ips" 1183 | ] 1184 | }, 1185 | "text": { 1186 | "status": "generated", 1187 | "div": "

Generated Narrative with Details

id: IPS-examples-Observation-01-3

meta:

status: final

category: Laboratory (Details : {http://terminology.hl7.org/CodeSystem/observation-category code 'laboratory' = 'Laboratory)

code: Bacteria identified in Isolate (Details : {LOINC code '42803-7' = 'Bacteria identified in Isolate', given as 'Bacteria identified in Isolate'})

subject: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

effective: Dec 10, 2017 8:20:00 AM

performer: http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02

value: Methicillin resistant Staphylococcus aureus (Details : {SNOMED CT code '115329001' = 'MRSA', given as 'Methicillin resistant Staphylococcus aureus'})

note: Healthy carrier of MRSA

" 1188 | }, 1189 | "status": "final", 1190 | "category": [ 1191 | { 1192 | "coding": [ 1193 | { 1194 | "system": "http://terminology.hl7.org/CodeSystem/observation-category", 1195 | "code": "laboratory" 1196 | } 1197 | ] 1198 | } 1199 | ], 1200 | "code": { 1201 | "coding": [ 1202 | { 1203 | "system": "http://loinc.org", 1204 | "code": "42803-7", 1205 | "display": "Bacteria identified in Isolate" 1206 | } 1207 | ] 1208 | }, 1209 | "subject": { 1210 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 1211 | }, 1212 | "effectiveDateTime": "2017-12-10T08:20:00+01:00", 1213 | "performer": [ 1214 | { 1215 | "reference": "http://hapi.fhir.org/baseR4/Organization/IPS-examples-Organization-02" 1216 | } 1217 | ], 1218 | "valueCodeableConcept": { 1219 | "coding": [ 1220 | { 1221 | "system": "http://snomed.info/sct", 1222 | "code": "115329001", 1223 | "display": "Methicillin resistant Staphylococcus aureus" 1224 | } 1225 | ] 1226 | }, 1227 | "note": [ 1228 | { 1229 | "text": "Healthy carrier of MRSA" 1230 | } 1231 | ] 1232 | } 1233 | }, 1234 | { 1235 | "fullUrl": "http://hapi.fhir.org/baseR4/AllergyIntolerance/IPS-examples-AllergyIntolerance-02", 1236 | "resource": { 1237 | "resourceType": "AllergyIntolerance", 1238 | "id": "IPS-examples-AllergyIntolerance-02", 1239 | "meta": { 1240 | "profile": [ 1241 | "http://hl7.org/fhir/uv/ips/StructureDefinition/AllergyIntolerance-uv-ips" 1242 | ] 1243 | }, 1244 | "text": { 1245 | "status": "generated", 1246 | "div": "

Generated Narrative with Details

id: IPS-examples-AllergyIntolerance-02

meta:

identifier: 3a462598-009c-484a-965c-d6b24a821424

clinicalStatus: Active (Details : {http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical code 'active' = 'Active)

verificationStatus: Confirmed (Details : {http://terminology.hl7.org/CodeSystem/allergyintolerance-verification code 'confirmed' = 'Confirmed)

type: allergy

category: medication

criticality: high

code: No known food allergies (Details : {http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips code 'no-known-food-allergies' = 'No known food allergies)

patient: http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01

onset: Jan 1, 2010

" 1247 | }, 1248 | "identifier": [ 1249 | { 1250 | "system": "urn:oid:1.2.3.999", 1251 | "value": "3a462598-009c-484a-965c-d6b24a821424" 1252 | } 1253 | ], 1254 | "clinicalStatus": { 1255 | "coding": [ 1256 | { 1257 | "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical", 1258 | "code": "active" 1259 | } 1260 | ] 1261 | }, 1262 | "verificationStatus": { 1263 | "coding": [ 1264 | { 1265 | "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification", 1266 | "code": "confirmed" 1267 | } 1268 | ] 1269 | }, 1270 | "type": "allergy", 1271 | "category": [ 1272 | "medication" 1273 | ], 1274 | "criticality": "high", 1275 | "code": { 1276 | "coding": [ 1277 | { 1278 | "system": "http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips", 1279 | "code": "no-known-food-allergies" 1280 | } 1281 | ] 1282 | }, 1283 | "patient": { 1284 | "reference": "http://hapi.fhir.org/baseR4/Patient/IPS-examples-Patient-01" 1285 | }, 1286 | "onsetDateTime": "2010" 1287 | } 1288 | } 1289 | ] 1290 | } --------------------------------------------------------------------------------